CTLA4 and rheumatoid arthritis: Genetic studies of RA-related genes revealed that T-cell-related genes, including HLA-DR, PTPN22, and CTLA4, are involved in RA (25), and that treatment that targets T cells is as effective as anti-TNF therapy (26).